Cargando…

Rosiglitazone RECORD study: glucose control outcomes at 18 months

AIMS: To compare glucose control over 18 months between rosiglitazone oral combination therapy and combination metformin and sulphonylurea in people with Type 2 diabetes. METHODS: RECORD, a multicentre, parallel-group study of cardiovascular outcomes, enrolled people with an HbA(1c) of 7.1–9.0% on m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Home, P D, Jones, N P, Pocock, S J, Beck-Nielsen, H, Gomis, R, Hanefeld, M, Komajda, M, Curtis, P
Formato:	Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2007
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1974811/ https://www.ncbi.nlm.nih.gov/pubmed/17517066 http://dx.doi.org/10.1111/j.1464-5491.2007.02160.x

Ejemplares similares

Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial
por: Komajda, Michel, et al.
Publicado: (2010)

Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: A randomized controlled trial (the RECORD study)
por: Komajda, Michel, et al.
Publicado: (2008)

Incidence and Prevalence of Unrecognized Myocardial Infarction in People With Diabetes: A substudy of the Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycemia in Diabetes (RECORD) study
por: MacDonald, Michael R., et al.
Publicado: (2011)

Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycaemia in Diabetes) clinical trials
por: Home, P. D., et al.
Publicado: (2010)

Impact of rosiglitazone meta-analysis on use of glucose-lowering medications
por: Morrow, Richard L, et al.
Publicado: (2010)

Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs
por: Colhoun, H. M., et al.
Publicado: (2012)

A double-blind randomized study comparing the effects of continuing or not continuing rosiglitazone + metformin therapy when starting insulin therapy in people with Type 2 diabetes1
por: Home, P D, et al.
Publicado: (2007)

Leukemia and rosiglitazone
por: Yavasoglu, Irfan, et al.
Publicado: (2016)

The Janus face of rosiglitazone
por: Pich, Christine, et al.
Publicado: (2018)

In vivo effects of rosiglitazone in a human neuroblastoma xenograft
por: Cellai, I, et al.
Publicado: (2010)

Evidence that rosiglitazone acts as an antidegradative agent on cartilage cells in vitro
por: Francois, M, et al.
Publicado: (2003)

Effect of Rosiglitazone and Ramipril on β-Cell Function in People With Impaired Glucose Tolerance or Impaired Fasting Glucose: The DREAM trial
por: Hanley, Anthony J., et al.
Publicado: (2010)

Antineoplastic effects of rosiglitazone and PPARγ transactivation in neuroblastoma cells
por: Cellai, I, et al.
Publicado: (2006)

Rosiglitazone diminishes the high-glucose-induced modulation of 5-fluorouracil cytotoxicity in colorectal cancer cells
por: Lau, Meng-Fei, et al.
Publicado: (2018)

Topical Rosiglitazone Is an Effective Anti-Scarring Agent in the Cornea
por: Huxlin, Krystel R., et al.
Publicado: (2013)

Rosiglitazone and Fenofibrate Additive Effects on Lipids
por: Slim, Ahmad, et al.
Publicado: (2011)

Rosiglitazone Prior Authorization Safety Policy: A Cohort Study
por: Starner, Catherine I., et al.
Publicado: (2012)

Rosiglitazone promotes glucose metabolism of GIFT tilapia based on the PI3K/Akt signaling pathway
por: Guan, Dong‐Yan, et al.
Publicado: (2021)

Rosiglitazone enhances the apoptotic effect of 5-fluorouracil in colorectal cancer cells with high-glucose-induced glutathione
por: Lau, Meng-Fei, et al.
Publicado: (2019)

Rosiglitazone treatment and cardiovascular disease in the Veterans Affairs Diabetes Trial
por: Florez, H, et al.
Publicado: (2015)

Can the electrophysiological action of rosiglitazone explain its cardiac side effects?
por: Kecskeméti, Valéria, et al.
Publicado: (2011)

PLA-PEG Nanoparticles Improve the Anti-Inflammatory Effect of Rosiglitazone on Macrophages by Enhancing Drug Uptake Compared to Free Rosiglitazone
por: Giacalone, Giovanna, et al.
Publicado: (2018)

Rosiglitazone activation of PPARγ suppresses fractalkine signaling
por: Wan, Yihong, et al.
Publicado: (2010)

Monthly Record of Deaths in the City of Buffalo
por: Strong, P. H.
Publicado: (1859)

Monthly Record of Deaths in the City of Buffalo
por: Strong, P. H.
Publicado: (1859)

Monthly Record of Deaths in the City of Buffalo
por: Strong, P. H.
Publicado: (1859)

A phase II trial with rosiglitazone in liposarcoma patients
por: Debrock, G, et al.
Publicado: (2003)

Rosiglitazone and Myocardial Infarction in Patients Previously Prescribed Metformin
por: Dormuth, Colin R., et al.
Publicado: (2009)

Incidence of Diabetes Following Ramipril or Rosiglitazone Withdrawal
Publicado: (2011)

Safety and efficacy of rosiglitazone in the elderly diabetic patient
por: Viljoen, Adie, et al.
Publicado: (2009)

Rosiglitazone use and post-discontinuation glycaemic control in two European countries, 2000–2010
por: Ehrenstein, V, et al.
Publicado: (2013)

The effect of Korean Red Ginseng extract on rosiglitazone-induced improvement of glucose regulation in diet-induced obese mice
por: Oh, Mi-Jeong, et al.
Publicado: (2017)

Rosiglitazone Mitigates Dexamethasone-Induced Depression in Mice via Modulating Brain Glucose Metabolism and AMPK/mTOR Signaling Pathway
por: Alhaddad, Aisha, et al.
Publicado: (2023)

The impact of acute rosiglitazone on insulin pharmacokinetics at the blood‐brain barrier
por: Galindo, Demi C., et al.
Publicado: (2020)

Spectrophotometric Determination of Poorly Water Soluble Drug Rosiglitazone Using Hydrotropic Solubilization technique
por: Sherje, A. P., et al.
Publicado: (2011)

Rosiglitazone Prevents High Glucose-Induced Vascular Endothelial Growth Factor and Collagen IV Expression in Cultured Mesangial Cells
por: Whiteside, Catharine, et al.
Publicado: (2009)

Beneficial Effects of Aerobic Exercise Training Combined with Rosiglitazone on Glucose Metabolism in Otsuka Long Evans Tokushima Fatty Rats
por: Piao, Shan-Ji, et al.
Publicado: (2017)

Correction: Rosiglitazone and Myocardial Infarction in Patients Previously Prescribed Metformin
por: Dormuth, Colin R., et al.
Publicado: (2010)

Association between industry affiliation and position on cardiovascular risk with rosiglitazone: cross sectional systematic review
por: Wang, Amy T, et al.
Publicado: (2010)

The PPARγ Agonist Rosiglitazone Impairs Colonic Inflammation in Mice with Experimental Colitis
por: Ramakers, Julian D., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_k74jnvrkmn9gljjepvjcacdqeg